Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

2,608 public trials 494 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Completed

Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma

NCT00531284

Conditions
Adnexal Diseases, Blood Protein Disorders, Bronchial Neoplasms, +47 more
Locations
  • Pinnacle Oncology Scottsdale, Arizona, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States
View Trial Details
Completed

Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function

NCT01393964

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • Investigative Clinical Research Of Indiana, Llc Indianapolis, Indiana, United States
  • University Of Iowa Hospitals And Clinics Iowa City, Iowa, United States
  • University Of Maryland Baltimore, Maryland, United States
View Trial Details
Completed

A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms

NCT02842229

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +28 more
Locations
  • Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
  • Hospital Durán I Reynals L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital Parc Taulí Sabadell, Barcelona, Spain
  • C.H. Universitario A Coruña A Coruña, La Coruña, Spain
View all 15 locations
View Trial Details
Completed

Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer

NCT00104923

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Blood Protein Disorders, +58 more
Locations
  • USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
  • Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States
  • M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States
  • Joe Arrington Cancer Research and Treatment Center Lubbock, Texas, United States
View Trial Details
Completed

Sequential Trial on Reduced Intensity Conditioning (RIC) Allogeneic Transplantation

NCT01460420

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • Medizinische Klinik and Poliklinik II, University Hospital Würzburg, Germany
  • S Giovanni Battista Hospital Torino, Italy
  • Azienda Ospedaliera Universitaria di Udine Udine, Italy
  • Hospital Clinic i Provincial, Barcelona, Spain
View Trial Details

Related conditions